N. Bodor

N. Bodor, M. A. Khan, M A Khan, 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Selective 17α-Alkylation of Cortienic Acid Derivatives in a Solid-Liquid Biphasic System

N. Bodor, P. Druzgala, 1990 .

Molecular Size-Based Model To Describe Simple Organic Liquids

Nicholas Bodor, Peter Buchwald, N. Bodor, 1998 .

The Effect of 2-Hydroxypropyl-ß-Cyclodextrin on the Solubility, Stability and Brain Targeting of Chemical Delivery Systems for Neuropeptides

N. Bodor, J. Wu, W.‐M. Wu, 1999 .

Computer-aided drug design: the role of quantitative structure-property, structure-activity and structure-metabolism relationships (QSPR, QSAR, QSMR)

Nicholas Bodor, Peter Buchwald, N. Bodor, 2002 .

Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites

N. Bodor, P. Buchwald, 2004, Molecular biotechnology.

Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.

N. Bodor, P. Buchwald, 2002, Methods in molecular biology.

Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation.

N. Bodor, P. Buchwald, C. Ricordi, 2010, Die Pharmazie.

A NOVEL CHLORAMINE COMPOUND FOR WATER DISINFECTION1

N. Bodor, S. D. Worley, H. D. Burkett, 1981 .

Effects of a brain-enhanced estrogen delivery system on tail-skin temperature of the rat: implications for menopausal hot flush.

N. Bodor, J. Simpkins, M. Rahimy, 1991, Maturitas.

Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants.

N. Bodor, P. Kovacs, P. Buchwald, 2006, Die Pharmazie.

A dihydropyridine conjugate which generates high and sustained levels of the corresponding pyridinium salt in the brain does not exhibit neurotoxicity in cynomolgus monkeys

N. Bodor, M. Brewster, K. S. Estes, 1988, Neuroscience Letters.

Improved delivery through biological membranes. 4. Prodrugs of L-dopa.

N. Bodor, T. Higuchi, K. Sloan, 1977, Journal of medicinal chemistry.

Effects of a brain-enhanced chemical delivery system for estradiol on body weight and serum hormones in middle-aged male rats.

N. Bodor, J. Simpkins, M. Brewster, 1988, Endocrine research.

Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.

N. Bodor, A. Harget, E. W. Phillips, 1983, Journal of medicinal chemistry.

Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids.

N. Bodor, P. Buchwald, 2006, Current pharmaceutical design.

Targeted drug delivery to the brain via phosphonate derivatives II. Anionic chemical delivery system for zidovudine (AZT)

N. Bodor, P. Buchwald, L. Prokai, 1998 .

Brain-Targeted Delivery of Estrogens

N. Bodor, J. Simpkins, M. Brewster, 1990, Reviews in the neurosciences.

Synthesis, characterization and in vitro evaluation of various sulfonamide chemical delivery systems

N. Bodor, M. Brewster, K. Seyda, 1991 .

Identification of Major Esterase Involved in Hydrolysis of Soft Anticholinergic (2R3'R-SGM) Designed From Glycopyrrolate in Human and Rat Tissues.

N. Bodor, Kayoko Ohura, T. Imai, 2019, Journal of pharmaceutical sciences.

Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats

N. Bodor, P. Buchwald, F. Huang, 2008, The Journal of pharmacy and pharmacology.

New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox

N. Bodor, I. Szelenyi, I. Kurucz, 2004, Pharmacology Biochemistry and Behavior.

Enhanced Brain Delivery of Amino Acids and Peptides Through the Use of Redox Targeting Systems

N. Bodor, M. Brewster, W. Anderson, 1992 .

Soft corticosteroids for local immunosuppression: exploring the possibility for the use of loteprednol etabonate for islet transplantation.

N. Bodor, P. Buchwald, C. Ricordi, 2008, Die Pharmazie.

A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system.

N. Bodor, J. Simpkins, M. Rahimy, 1989, Journal of steroid biochemistry.

Hydroxymethyl and acyloxymethyl prodrugs of theophylline: enhanced delivery of polar drugs through skin

N. Bodor, K. Sloan, 1982 .

Targeting drugs to the brain by redox chemical delivery systems

N. Bodor, L. Prokai, K. Prokai-Tatrai, 2000, Medicinal research reviews.

Novel approaches to design and deliver safe and effective antiglaucoma agents to the eye

N. Bodor, I. Reddy, 1994 .

Brain-Enhanced Delivery of Anti-Dementia Drugs

N. Bodor, M. Brewster, E. Pop, 1989 .

Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.

N. Bodor, P. Buchwald, N. Mori, 2008, Die Pharmazie.

Pharmacological effects of some newly developed soft anticholinergics and a receptor-binding QSAR study.

N. Bodor, P. Buchwald, G. Hochhaus, 2006, Die Pharmazie.

A convenient synthesis of (acyloxy)alkyl .alpha.-ethers of phenols

N. Bodor, K. Sloan, J. Kaminski, 1983 .

Dichloroacetate derivatives. Metabolic effects and pharmacodynamics in normal rats.

N. Bodor, P. Stacpoole, Y. Oshiro, 1987, Life sciences.

Reactivity of biologically important reduced pyridines V. Relative importance of electron versus proton loss in ferricyanide-mediated oxidation of dihydronicotinamides

N. Bodor, M. Brewster, Z. Gabányi, 1989 .

Soft Drugs Based on Hydrocortisone: The Inactive Metabolite Approach and Its Application to Steroidal Antiinflammatory Agents

N. Bodor, T. Loftsson, R. Little, 1999, Pharmaceutical Research.

Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol.

N. Bodor, J. Simpkins, M. Brewster, 1988, Life sciences.

Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs

N. Bodor, J. Simpkins, M. Brewster, 1991, Pharmaceutical Research.

Redox delivery system for brain-specific, sustained release of dopamine.

N. Bodor, J. Simpkins, 1983, Science.

Improved Delivery Through Biological Membranes. XLV. Synthesis, Physical-Chemical Evaluation, and Brain Uptake Studies of 2-Chloroethyl Nitrosourea Delivery Systems

N. Bodor, K. Raghavan, M. Brewster, 1992, Pharmaceutical Research.

Applications of chemically-modified cyclodextrins: use of hydroxypropyl-β-cyclodextrin as an enabling excipient for brain targeting, redox-based derivatives of estradiol A review of preclinical and clinical findings

N. Bodor, M. Brewster, T. Loftsson, 2004 .

Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems

N. Bodor, P. Buchwald, 2005, The AAPS Journal.

Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.

N. Bodor, K. Török, Z. Nagy, 2004, Die Pharmazie.

Application of semiempirical molecular orbital techniques to the study of peroxidase-mediated oxidation of phenols, anilines, sulfides and thiobenzamides

N. Bodor, M. Brewster, D. Doerge, 1991 .

A non-surfactant formulation for alfaxalone based on an amorphous cyclodextrin : activity studies in rats and dogs

N. Bodor, M. Brewster, K. S. Estes, 1990 .

New Water-Soluble Pilocarpine Derivatives with Enhanced and Sustained Muscarinic Activity

N. Bodor, P. Druzgala, Scott Smith, 1992, Pharmaceutical Research.

Water soluble pilocarpine prodrugs with sustained intraocular activity in normotensive rabbits and in glaucomatous beagles

N. Bodor, P. Druzgala, 1994 .

In Vitro and In Vivo Evaluations of Dihydroquinoline- and Dihydroisoquinoline-based Targetor Moieties for Brain-specific Chemical Delivery Systems

N. Bodor, P. Buchwald, H. Farag, 2002, Journal of drug targeting.

Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins.

N. Bodor, M. Brewster, K. S. Estes, 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

Synthesis and Evaluation of a Novel Chemical Delivery System of Zidovudine with Increased Stability at Low pH

N. Bodor, M. Brewster, Zongliang Liu, 2011 .

Substituent effects on the stability of 1,4-dihydropyridines

N. Bodor, M. Brewster, E. Pop, 1995 .

Stability of the 1,3-substituted 1,4-dihydropyridines: Substituent effects on the acid catalyzed hydration and oxidation reactions

N. Bodor, M. Brewster, E. Pop, 1994 .

A Dihydroisoquinoline Targetor-Based Acid Resistant Chemical Delivery System of Azidothymidine (AZT)

N. Bodor, M. Brewster, Zongliang Liu, 1993 .

Reactivity of biologically important reduced pyridines. IV. Effect of substitution on ferricyanide-mediated oxidation rates of various 1,4-dihydropyridines

N. Bodor, M. Brewster, H. Farag, 1989 .

Improved delivery through biological membranes. XXX. Synthesis and biological aspects of a 1,4-dihydropyridine based chemical delivery system for brain-sustained delivery of hydroxy CCNU.

N. Bodor, K. Raghavan, E. Shek, 1987, Anti-cancer drug design.

Brain-specific chemical delivery systems for beta-lactam antibiotics. Synthesis and properties of some dihydropyridine and dihydroiosquinoline derivatives of benzylpenicillin.

N. Bodor, E. Shek, E. Pop, 1989, Journal of medicinal chemistry.

Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins.

N. Bodor, M. Brewster, N Bodor, 1991, Journal of pharmaceutical sciences.

Improved Delivery Through Biological Membranes. XXXVII. Synthesis and Stability of Novel Redox Derivatives of Naproxen and Indomethacin

N. Bodor, M. Phelan, 1989, Pharmaceutical Research.

Improved delivery through biological membranes XIX: Novel redox carriers for brain-specific chemical delivery systems.

N. Bodor, A. Abdelalim, 1985, Journal of pharmaceutical sciences.

Improved delivery through biological membranes XIV: Brain-specific, sustained delivery of testosterone using a redox chemical delivery system.

N. Bodor, H. Farag, 1984, Journal of pharmaceutical sciences.

Asymmetric synthesis of enantiomeric cyclophosphamides

N. Bodor, Tadao Satô, K. Nakagawa, 1983 .

Soft drugs. 3. A new class of anticholinergic agents.

R Woods, N. Bodor, N Bodor, 1980, Journal of medicinal chemistry.

Site-specific, sustained release of drugs to the brain.

N. Bodor, M. Brewster, N Bodor, 1981, Science.

Formation, stability, and protonation of dihydropyridines. A MINDO/3 study

N. Bodor, R. Pearlman, 1978 .

Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride.

N. Bodor, E. Shek, T. Higuchi, 1976, Journal of medicinal chemistry.

Contributions of Molecular Orbital Techniques to the Study of Dihydropyridines

N. Bodor, M. Brewster, E. Pop, 1994 .

Reactivity of biologically important reduced pyridines

N. Bodor, M. Brewster, J. Kaminski, 1990 .

Theoretical studies on the hydride transfer between 1-methyl-1,4-dihydronicotinamide and its corresponding pyridinium salt

N. Bodor, M. Brewster, J. Kaminski, 1988 .

Correlation between hydride transfer and one-electron oxidation of dihydropyridines and heterocycles

N. Bodor, J. Kaminski, 1988 .

Oxidation of aryloxyaminoalcohols with activated dimethylsulfoxide; a novel C-N oxidation facilitated by neighboring group effect

N. Bodor, A. Simay, Laszlo Prokal, 1989 .

13C NMR spectroscopy of 4,5- and 5,6-double bond isomers of spiro-3-steroidal ketone derivatives

N. Bodor, R. Little, K. Sloan, 1981 .

Acylation of the 4,5- and 5,6-double bond isomers of 3-steroidal thiazolidines: The chemical stability of spiro-3-steroidal 4,5- and 5,6-double bond isomers

N. Bodor, K. Sloan, J. Zupan, 1981 .

A convenient method of anion exchange in quaternary salts

N. Bodor, J. Kaminski, K. Knutson, 1978 .

Solubilization and electrochemical stabilization of substituted phenols through the use of 2-hydroxypropyl-β-cyclodextrin

N. Bodor, M. Brewster, C. Kibbey, 1994 .

The use of 2-hydroxypropyl-β-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogs

N. Bodor, M. Brewster, H. Derendorf, 1990 .

Water Soluble Complexes of a Brain-Targeted Drug Delivery System

N. Bodor, M. Brewster, T. Loftsson, 1988 .

Theoretical studies of inclusion complexes of α- and β-cyclodextrin with benzoic acid and phenol

N. Bodor, J. Watts, Ming-Ju Huang, 1997 .

The effects of 2-hydroxypropyl-β-cyclodextrin on the solubility and stability of chlorambucil and melphalan in aqueous solution

N. Bodor, T. Loftsson, S. Björnsdóttir, 1989 .

The potential use of cyclodextrins in parenteral formulations.

N. Bodor, Warren C. Stern, J. Simpkins, 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster.

N. Bodor, P. Buchwald, 2016, Journal of pharmaceutical sciences.

Brain-targeted delivery of estradiol

N. Bodor, P. Buchwald, 2006 .

Formulation development for a zidovudine chemical delivery system 2. Towards oral and non-parenteral dosage forms

N. Bodor, M. Brewster, S. Amselem, 1995 .

Preparation, Characterization, and Anesthetic Properties of 2-Hydroxypropyl-β-cyclodextrin Complexes of Pregnanolone and Pregnenolone in Rat and Mouse

N. Bodor, M. Brewster, T. Loftsson, 1995 .

Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex.

N. Bodor, B. McKiernan, M. A. González, 1993, Journal of pharmaceutical sciences.

Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits.

N. Bodor, M. Brewster, W. Anderson, 1991, Journal of pharmaceutical sciences.

An AM1 molecular orbital study of α-D-glucopyranose and β-maltose : evaluation and implications

N. Bodor, M. Dewar, M. Brewster, 1993 .

Stabilization of aspartame by cyclodextrins

N. Bodor, M. Brewster, T. Loftsson, 1991 .

Solubilization and Stabilization of a Benzylpenicillin Chemical Delivery System by 2-Hydroxypropyl-β-cyclodextrin

N. Bodor, T. Loftsson, E. Pop, 1991, Pharmaceutical Research.

The effects of cyclodextrins on transdermal delivery of drugs

N. Bodor, T. Loftsson, B. Ólafsdóttir, 1991 .

Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro.

N. Bodor, T. Loftsson, G. Somogyi, 1989, Acta pharmaceutica Nordica.

Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.

N. Bodor, W. Wu, J. Drustrup, 2000, Die Pharmazie.

Theoretical studies on the structures of natural and alkylated cyclodextrins.

N. Bodor, J. Watts, M. J. Huang, 1995, Journal of pharmaceutical sciences.

Formulation development for a zidovudine chemical delivery system 1. Parenteral dosage forms

N. Bodor, M. Brewster, S. Amselem, 1995 .

A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats.

N. Bodor, J. Simpkins, M. Brewster, 1987, Life sciences.

Improved delivery through biological membranes. XXII. Synthesis and distribution of brain-selective estrogen delivery systems

N. Bodor, M. Brewster, J. McCornack, 1987 .

Sustained brain-specific delivery of estradiol causes long-term suppression of luteinizing hormone secretion.

N. Bodor, J. Simpkins, M. Brewster, 1986, Journal of medicinal chemistry.

[29] Targeting of drugs to the brain

Nicholas Bodor, N. Bodor, 1985 .

Problems of delivery of drugs to the brain.

N. Bodor, M. Brewster, 1982, Pharmacology & therapeutics.

Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions.

N. Bodor, M. Brewster, R. Sawchuk, 1997, Journal of pharmaceutical sciences.

Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins.

N. Bodor, M. Brewster, H. Derendorf, 1988, Journal of pharmaceutical sciences.

Theoretical study of some heterocyclic amines with applications to the chemistry of 9‐amino‐1,2,3,4‐tetrahydroacridine

N. Bodor, M. Brewster, E. Pop, 1989 .

Micellar acceleration of organophosphate hydrolysis by hydroximinomethylpyridinium type surfactants

N. Bodor, T. Higuchi, R. Enever, 1978 .

Effects of a Brain-Enhanced Chemical Delivery System for Estradiol on Body Weight and Food Intake in Intact and Ovariectomized Rats

N. Bodor, J. Simpkins, W. Anderson, 1989, Pharmaceutical Research.

Chronic weight loss in lean and obese rats with a brain-enhanced chemical delivery system for estradiol

N. Bodor, J. Simpkins, K. S. Estes, 1988, Physiology & Behavior.

Theoretical studies of inclusion complexes of β‐cyclodextrin with methylated benzoic acids

N. Bodor, J. Watts, Ming-Ju Huang, 1997 .

Redox targeting of LY231617, an antioxidant with potential use in the treatment of brain damage

N. Bodor, M. Brewster, J. Panetta, 1996 .

Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs.

N. Bodor, T. Loftsson, 1981, Journal of pharmaceutical sciences.

Effect of oleic acid on diffusion of drugs through hairless mouse skin.

N. Bodor, T. Loftsson, R. Soliman, 1989, Acta pharmaceutica Nordica.

A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits.

N. Bodor, N Bodor, W M Wu, 1992, Current eye research.

Designing safer ophthalmic drugs by soft drug approaches.

N. Bodor, 1994, Journal of ocular pharmacology.

Improved brain delivery of antiviral agents through the use of redox targeting

N. Bodor, M. Brewster, 1994 .

Enhanced delivery of ganciclovir to the brain through the use of redox targeting

N. Bodor, K. Raghavan, M. Brewster, 1994, Antimicrobial Agents and Chemotherapy.

Improved delivery through biological membranes. XLI. Brain-enhanced delivery of chlorambucil

N. Bodor, M. Brewster, K. S. Estes, 1989 .

Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.

Y Q Zhang, N. Bodor, C. Yu, 1997, Journal of neurosurgery.

Dithionite reduction of pyridinium salts: an AM1 study

N. Bodor, M. Brewster, E. Pop, 1993 .

Improved delivery through biological membranes XX: Nicotinamide----dihydronicotinamide based ester-linked redox carrier systems.

N. Bodor, A. M. Abdelim, 1986, Journal of pharmaceutical sciences.

Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues.

N. Bodor, S. Yoon, A. Juhasz, 2000, Journal of medicinal chemistry.

Soft quaternary anticholinergics: comprehensive quantitative structure-activity relationship (QSAR) with a linearized biexponential (LinBiExp) model.

N. Bodor, P. Buchwald, 2006, Journal of medicinal chemistry.

On the reactivity of CFnH3−nCH2X (n = 0, 1, 2, and 3, and X = H or Halogen atom)

N. Bodor, C. Szantay, Ming-Ju Huang, 1992 .

Improved Delivery through Biological Membranes. Synthesis and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 2′ and 3′ Derivatives

N. Bodor, M. Brewster, P. Druzgala, 1991 .

Prodrugs of 6-thiopurines: enhanced delivery through the skin.

N. Bodor, M. Hashida, T. Higuchi, 1983, Journal of pharmaceutical sciences.

Improved delivery through biological membranes. 3. Delivery of N-methylpyridinium-2-carbaldoxime chloride through the blood-brain barrier in its dihydropyridine pro-drug form.

N. Bodor, E. Shek, T. Higuchi, 1976, Journal of medicinal chemistry.

Improved delivery through biological membranes. 2. Distribution, excretion, and metabolism of N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride.

N. Bodor, E. Shek, T. Higuchi, 1976, Journal of medicinal chemistry.

Delivery of a quaternary pyridinium salt across the blood-brain barrier by its dihydropyridine derivative

N. Bodor, E. Shek, T. Higuchi, 1975, Science.

Octanol–water partition of nonzwitterionic peptides: Predictive power of a molecular size‐based model

P Buchwald, N. Bodor, P. Buchwald, 1998, Proteins.

Improved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials.

N. Bodor, T. Murakami, E. Shek, 1989, Journal of pharmaceutical sciences.

Improved anticonvulsant activity of phenytoin by a redox brain delivery system I: Synthesis and some properties of the dihydropyridine derivatives.

N. Bodor, T. Murakami, E. Shek, 1989, Journal of pharmaceutical sciences.

N-halo derivatives III: stabilization of nitrogen-chlorine bond in N-chloroamino acid derivatives.

N. Bodor, T. Higuchi, J. Kaminski, 1976, Journal of pharmaceutical sciences.

Properties of a new chloramine disinfectant and detoxicant.

N. Bodor, S. D. Worley, E. Mora, 1982, Poultry science.

N-Halo derivatives V: Comparative antimicrobial activity of soft N-chloramine systems.

N. Bodor, T. Higuchi, M. Huycke, 1976, Journal of pharmaceutical sciences.

Recent advances in retrometabolic design approaches.

N. Bodor, Nicholas Bodor, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Enhanced brain delivery of 2′-fluoro-5-methylarabinosyluracil

N. Bodor, M. Brewster, W. Anderson, 1992 .

Improved Delivery through Biological Membranes. Synthesis, Characterization and Antiviral Activity of a Series of Ribavirin Chemical Delivery Systems: 5 and Carboxamide Derivatives

N. Bodor, M. Brewster, R. Sidwell, 1991 .

Redox Drug Delivery Systems for Targeting Drugs to the Brain a

N. Bodor, N Bodor, 1987, Annals of the New York Academy of Sciences.

Improved delivery through biological membranes XXV. Enhanced and sustained delivery of trifluorothymidine to the brain using a dihydropyridine in equilibrium pyridinium salt type redox delivery system.

N. Bodor, A. el-Koussi, 1987, Drug design and delivery.

Potential Treatment of Herpes Simplex Virus Encephalitis by Brain‐Specific Delivery of Trifluorothymidine Using a Dihydropyridine ⇆ Pyridinium Salt Type Redox Delivery System

N. Bodor, K. Rand, H. Houck, 1986 .

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. 4. PRODRUGS OF L-DOPA

N. Bodor, T. Higuchi, K. Sloan, 1978 .

PRODRUGS OF 6-THIOPURINES: ENHANCED DELIVERY THROUGH THE SKIN

N. Bodor, M. Hashida, T. Higuchi, 1983 .

Soft drugs. 21. Design and evaluation of soft analogs of propantheline.

N. Bodor, G. Kumar, N Bodor, 1996, Journal of pharmaceutical sciences.

Regioselective O-alkylation of cortienic acid and synthesis of a new class of glucocorticoids containing a 17α-alkoxy, a 17α-(1′-alkoxyethyloxy), a 17α-alkoxymethyloxy, or a 17α-methylthiomethyloxy function

Nicholas Bodor, N. Bodor, P. Druzgala, 1991, Steroids.

Soft drugs—10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: Loteprednol etabonate

N. Bodor, N. Bodor, P. Druzgala, 1991, The Journal of Steroid Biochemistry and Molecular Biology.

Soft drugs. 2. Soft alkylating compounds as potential antitumor agents.

N. Bodor, N Bodor, J J Kaminski, 1980, Journal of medicinal chemistry.

Improved delivery through biological membranes. LXI: Design, synthesis, and evaluation of a lipolol-based intradermal drug targeting system for 5-fluorouracil.

N. Bodor, P. Chikhale, E. Márványos, 1994, Cancer Biotherapy.

Targeted drug delivery to the brain via phosphonate derivatives. I. Design, synthesis and evaluation of an anionic chemical delivery system for testosterone

N. Bodor, P. Buchwald, L. Prokai, 1998 .

Rational development of a soluble prodrug of a cytotoxic nucleoside: preparation and properties of arabinosyladenine 5'-formate.

N. Bodor, T. Higuchi, K. Sloan, 1975, Journal of pharmaceutical sciences.

A Convenient Preparation of Phosphate Diester Monoanions

N. Bodor, B. Krishnan, D. Winwood, 1990 .

Chapter 30 Prodrugs and Site-Specific Chemical Delivery Systems

Nicholas Bodor, N. Bodor, James J. Kaminski, 1987 .

Unified Pharmacogenetics-Based Parent–Metabolite Pharmacokinetic Model Incorporating Acetylation Polymorphism for Talampanel in Humans

N. Bodor, P. Buchwald, M. Pátfalusi, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Soft drugs. 7. Soft beta-blockers for systemic and ophthalmic use.

N. Bodor, N Bodor, A A el-Koussi, 1988, Journal of medicinal chemistry.

Redox approaches to drug delivery to the central nervous system.

N. Bodor, M. Brewster, 1992, NIDA research monograph.

Improved Delivery Through Biological Membranes LX: Intradermal Targeting of Acyclovir Using Redox-Based Chemical Drug Delivery Systems

N. Bodor, P. Chikhale, V. Venkatraghavan, 1996 .

The Effect of Dihydronicotinate N-Substitution on the Brain-Targeting Efficacy of a Zidovudine Chemical Delivery System

N. Bodor, M. Brewster, P. Druzgala, 1993, Pharmaceutical Research.

Improved delivery of acyclovir to the skin using a dihydrotrigonelline trigonelline redox carrier

N. Bodor, P. Chikhale, 1991 .

Soft drugs V: Thiazolidine-type derivatives of progesterone and testosterone.

N. Bodor, N Bodor, K B Sloan, 1982, Journal of pharmaceutical sciences.

Dose-Dependent Brain Delivery of Zidovudine Through the Use of a Zidovudine Chemical Delivery System

N. Bodor, M. Brewster, W. Anderson, 1995, Pharmaceutical Research.

Identification of esterase involved in the metabolism of two corticosteroid soft drugs

N. Bodor, T. Imai, A. Samir, 2017, Biochemical pharmacology.

Drug targeting via retrometabolic approaches.

N Bodor, P Buchwald, N. Bodor, 1997, Pharmacology & therapeutics.

Targeting drugs to the brain by sequential metabolism.

N. Bodor, 1995, NIDA research monograph.

Hydrolytic stability of allylic and phenolic esters of some synthetic cannabinoids: A theoretical (AM1) study

N. Bodor, M. Brewster, E. Pop, 1995 .

A theoretical study of the hydrolysis of some sterically hindered phenolic esters

N. Bodor, M. Brewster, E. Pop, 1992 .

Receptor binding studies of soft anticholinergic agents

N. Bodor, P. Buchwald, G. Hochhaus, 2001, AAPS PharmSci.

Pharmacokinetic and Pharmacodynamic Evaluations of the Zwitterionic Metabolite of a New Series of N-Substituted Soft Anticholinergics

N. Bodor, P. Buchwald, N. Mori, 2005, Pharmaceutical Research.

Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry.

N. Bodor, T. Szekeres, Á. Csanádi, 2004, Die Pharmazie.

Quantitative structure-metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters.

N. Bodor, P. Buchwald, 1999, Journal of medicinal chemistry.

Evidence for the reestablishment of copulatory behavior in castrated male rats with a brain-enhanced estradiol-chemical delivery system

N. Bodor, J. Simpkins, M. Brewster, 1987, Pharmacology Biochemistry and Behavior.

Determination of penicillins and cephalosporins using 3-bromo-4,4-dimethyl-2-oxazolidinone

N. Bodor, J. Kaminski, 1979 .

Novel Chemical Approaches for Sustained Drug Delivery

N. Bodor, T. Loftsson, 1987 .

Dose and Time-Course Evaluation of a Redox-Based Estradiol-Chemical Delivery System for the Brain. II. Pharmacodynamic Responses

N. Bodor, J. Simpkins, M. Rahimy, 1990, Pharmaceutical Research.

A Redox-Based System that Enhances Delivery of Estradiol to the Brain: Pharmacokinetic Evaluation in the Dog

N. Bodor, M. Brewster, H. Derendorf, 1990, Pharmaceutical Research.

High-Performance Liquid Chromatographic Assay of a Central Nervous System (CNS)-Directed Estradiol Chemical Delivery System and Its Application After Intravenous Administration to Rats

N. Bodor, M. Brewster, H. Derendorf, 1988, Pharmaceutical Research.

Improved anticonvulsant activity of phenytoin by a redox brain delivery system. III: Brain uptake and pharmacological effects.

N. Bodor, T. Murakami, E. Shek, 1989, Journal of pharmaceutical sciences.

Synthesis and evaluation of novel lidocaine sulfur analogs

N. Bodor, T. Loftsson, R. Caldwell, 1984 .

Soft drug design: General principles and recent applications

N. Bodor, P. Buchwald, 2000, Medicinal research reviews.

Soft Drugs 19. Pharmacokinetics, Metabolism and Excretion of a Novel Soft Corticosteroid, Loteprednol Etabonate, in Rats

N. Bodor, T. Murakami, Whei-mei Wu, 1995, Pharmaceutical Research.

Recent advances in the design and development of soft drugs.

N. Bodor, P. Buchwald, Nicholas Bodor, 2014, Die Pharmazie.

Retrometabolic Drug Design

N. Bodor, P. Buchwald, 2012 .

Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.

N. Bodor, P. Buchwald, W. Wu, 2010, Die Pharmazie.

Synthesis and pharmacological effects of new, N‐substituted soft anticholinergics based on glycopyrrolate

N. Bodor, P. Buchwald, X. Dai, 2005, The Journal of pharmacy and pharmacology.

Octanol-water partition: searching for predictive models.

P Buchwald, N. Bodor, P. Buchwald, 1998, Current medicinal chemistry.

Design and evaluation of new soft anticholinergic agents

Nicholas Bodor, Peter Buchwald, Attila Juhász, 1998 .

Design of Biologically Safer Chemicals

Nicholas Bodor, N. Bodor, 1996 .

The pharmacokinetics and transdermal delivery of loteprednol etabonate and related soft steroids

Nicholas Bodor, Thorsteinn Loftsson, N. Bodor, 1994 .

Soft drugs. 17: Quantitative structure-activity relationships of soft anticholinergics based on methatropine and methscopolamine.

N. Bodor, G. Kumar, N Bodor, 1994, Journal of pharmaceutical sciences.

Soft drugs--XVI. Design, evaluation and transdermal penetration of novel soft anticholinergics based on methatropine.

N. Bodor, G. Kumar, G N Kumar, 1993, Bioorganic & medicinal chemistry.

Soft drugs--XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine.

V Srinivasan, N. Bodor, G. Kumar, 1993, Bioorganic & medicinal chemistry.

Soft drugs. 13: Design and evaluation of phenylsuccinic analogs of scopolamine as soft anticholinergics.

N. Bodor, G. Kumar, G N Kumar, 1993, Drug design and discovery.

Soft drugs. 12: Design, syntheses and evaluation of soft anticholinergics.

N. Bodor, G. Kumar, G N Kumar, 1993, Drug design and discovery.

Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs.

N. Bodor, P. Druzgala, A. Ratka, 1992, Journal of pharmaceutical sciences.

A new method for the estimation of the aqueous solubility of organic compounds.

N. Bodor, N Bodor, M J Huang, 1992, Journal of pharmaceutical sciences.

An extended version of a novel method for the estimation of partition coefficients.

N. Bodor, N Bodor, M J Huang, 1992, Journal of pharmaceutical sciences.

Neural network studies. 1. Estimation of the aqueous solubility of organic compounds

Nicholas Bodor, Ming-Ju Huang, N. Bodor, 1991 .

Short acting soft mydriatics.

N. Bodor, N Bodor, R H Hammer, 1991, Current eye research.

Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes.

N. Bodor, P. Druzgala, N Bodor, 1991, Current eye research.

Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs.

N. Bodor, N Bodor, P Polgar, 1991, Life sciences.

Novel ‘soft’ β-blockers as potential safe antiglaucoma agents

Nicholas Bodor, N. Bodor, Alaaeldin Elkoussi, 1988 .

Soft drugs: Principles and methods for the design of safe drugs

N. Bodor, N Bodor, 1984, Medicinal research reviews.

Soft drugs 4. 3-Spirothiazolidines of hydrocortisone and its derivatives

Nicholas Bodor, Larry Caldwell, Kenneth B. Sloan, 1982 .

Designing safer drugs based on the soft drug approach

Nicholas Bodor, N. Bodor, 1982 .

Cardiovascular studies on different classes of soft drugs.

N. Bodor, A. Juhasz, 2000, Die Pharmazie.

Acid-catalyzed rearrangements of the dihydroxyacetone side chain in steroids during ketal exchange

N. Bodor, R. Little, K. Sloan, 1978 .

Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters.

N. Bodor, P. Buchwald, 2002, Die Pharmazie.

Structure-based estimation of enzymatic hydrolysis rates and its application in computer-aided retrometabolic drug design.

N. Bodor, P. Buchwald, 2000, Die Pharmazie.

Evaluation of a brain-targeting zidovudine chemical delivery system in dogs

N. Bodor, M. Brewster, H. Derendorf, 1997, Antimicrobial agents and chemotherapy.

Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.

N. Bodor, J. Wu, W. Wu, 2002, Die Pharmazie.

Elimination of a quaternary pyridinium salt delivered as its dihydropyridine derivative from brain of mice.

N. Bodor, S. Selk, R. G. Roller, 1978, Journal of pharmaceutical sciences.

A MINDO/3 study of a substituted benzo[b] isoquinolizinium salt ⇆ benzo[b] quinolizine system

N. Bodor, M. Brewster, 1986 .

ANALOGS OF TRYPTOPHAN

N. Bodor, M. Brewster, K. Prokai-Tatrai, 1994 .

Relative reactivity of 1,4‐ and 1,6‐dihydronicotinic acid derivatives to radically mediated oxidation—a theoretical and experimental evaluation

N. Bodor, A. Balaban, M. Brewster, 1995 .

Potency and Specificity of the Pharmacological Action of a New, Antiasthmatic, Topically Administered Soft Steroid, Etiprednol Dicloacetate (BNP-166)

N. Bodor, Á. Pataki, K. Török, 2003, Journal of Pharmacology and Experimental Therapeutics.

Antimicrobial activity of N-chloramine compounds.

N. Bodor, S. D. Worley, W. B. Wheatley, 1980, Journal of pharmaceutical sciences.

Improved Oral Bioavailability of the Brain-Targeting Estrogen, E2-CDS, through the Use of Carboxymethylethyl-β-Cyclodextrin

N. Bodor, M. Brewster, T. Murakami, 1996 .

Intravenous and Buccal 2-Hydroxypropyl-β-Cyclodextrin Formulations of E2-CDS — Phase I Clinical Trials

N. Bodor, M. Brewster, W. Anderson, 1996 .

Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting.

N. Bodor, M. Brewster, P. Druzgala, 1995, Journal of pharmaceutical sciences.

THE STABILITY IN WATER OF A NEW CHLORAMINE DISINFECTANT

N. Bodor, S. D. Worley, H. D. Burkett, 1983 .

On the structure of N‐chlorosuccinimide and N‐bromosuccinimide. A photoelectron spectroscopic study

N. Bodor, S. D. Worley, J. Kaminski, 1978 .

Mass spectra of a series of 3‐halo‐2‐oxazolidinones

N. Bodor, S. D. Worley, J. Kaminski, 1977 .

N-Halo derivatives VI: Microbiological and chemical evaluations of 3-chloro-2-oxazolidinones.

N. Bodor, T. Higuchi, M. Kosugi,, 1976, Journal of pharmaceutical sciences.

Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease.

N. Bodor, P. Buchwald, 2002, Drug discovery today.

Theoretical study of the stereoisomers of tetrahydrocannabinols

N. Bodor, Ming-Ju Huang, 1997 .

Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates.

N. Bodor, T. Higuchi, K. Sloan, 1978, Journal of pharmaceutical sciences.

Chemical delivery systems: evaluation of physicochemical properties and enzymatic stability of phenylephrone derivatives.

N. Bodor, M. A. Khan, I. Reddy, 1999, Pharmaceutical development and technology.

Formation of propranolol in the iris-ciliary body from its propranolol ketoxime precursor: a potential antiglaucoma drug

N. Bodor, A. Elkoussi, 1989 .

Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for beta-adrenergic blocking agents.

N. Bodor, T. Nakamura, M. Kano, 1988, Journal of medicinal chemistry.

Improved delivery through biological membranes VI. Potent sympathomimetic adrenalone derivatives

N. Bodor, J. Kaminski, R. G. Roller, 1978 .

Improved delivery through biological membranes VIII: Design, synthesis, and in vivo testing of true prodrugs of aspirin.

N. Bodor, T. Loftsson, J. Kaminski, 1981, Journal of pharmaceutical sciences.

PREPARATION OF O-(3,3,8,10,10-PENTAMETHYL-1,2-DITHIA-5,8-DIAZACYCLODECAN-5-YL)ETHYL O-PIVALOYLOXYMETHYL PHENYLPHOSPHONATE

N. Bodor, L. Prokai, K. Prokai-Tatrai, 1998 .

The photoelectron spectra of some heterocyclic compounds which contain N, O, Cl and Br

N. Bodor, S. D. Worley, N. Bodor, 1978 .

Rotational barriers in phenol and sterically congested phenol derivatives, an AM1 study

N. Bodor, M. Brewster, E. Pop, 1994 .

Theoretical aspects of cephalosporin isomerism

N. Bodor, M. Brewster, E. Pop, 2009 .

Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties

N. Bodor, T. Murakami, E. Bodor, 2023, Expert opinion on drug metabolism & toxicology.

Application of a Brain-Targeting Chemical Delivery System to 9-Amino-1,2,3,4-Tetrahydroacridine

N. Bodor, M. Brewster, K. Prokai-Tatrai, 1990, Pharmaceutical Research.

A simple, predictive, structure‐based skin permeability model

P Buchwald, N. Bodor, P. Buchwald, 2001, The Journal of pharmacy and pharmacology.

Isomeric interconversions in tamoxifen and related compounds: An AM1 study

N. Bodor, M. Brewster, E. Pop, 1995 .

Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations

N. Bodor, T. Murakami, E. Bodor, 2023, Expert opinion on drug metabolism & toxicology.

Soft Drugs. XX. Design, Synthesis, and Evaluation of Ultra-Short Acting Beta-Blockers

N. Bodor, Whei-mei Wu, Heetae Yang, 1995, Pharmaceutical Research.

Quantitative Structure Activity Relationships of Catechol Derivatives on Nerve Growth Factor Secretion in L-M Cells

N. Bodor, A. Kourounakis, 1995, Pharmaceutical Research.

Improved delivery through biological membranes VII. Dermal delivery of cromoglycic acid (cromolyn) via its prodrugs

N. Bodor, J. Zupan, S. Selk, 1980 .

A strategy for delivering peptides into the central nervous system by sequential metabolism.

N. Bodor, J. Simpkins, L. Prokai, 1992, Science.

The electronic structures of some biological piperazines

N. Bodor, S. D. Worley, J. Kaminski, 1978 .

A tryptamine analog with high affinity to the heart tissues is a potential antiarrhythmic agent

N. Bodor, H. Farag, P. Polgár, 2001, The Journal of pharmacy and pharmacology.

Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: synthesis and biological evaluation.

N. Bodor, L. Prokai, S. Yoon, 2000, Bioorganic & medicinal chemistry.

Retrometabolic drug design concepts in ophthalmic target-specific drug delivery

N. Bodor, 1995 .

Delivery of peptides into the central nervous system by sequential metabolism

N. Bodor, L. Prokai, 1994 .

Novel, cell‐penetrating molecular transporters with flexible backbones and permanently charged side‐chains

N. Bodor, P. Buchwald, Ü. Langel, 2007, The Journal of pharmacy and pharmacology.

Strategies to target kyotorphin analogues to the brain.

N. Bodor, L. Prokai, P. Chen, 1998, Journal of medicinal chemistry.

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. 13. BRAIN-SPECIFIC DELIVERY OF DOPAMINE WITH A DIHYDROPYRIDINE ⇌ PYRIDINIUM SALT TYPE REDOX DELIVERY SYSTEM

N. Bodor, H. Farag, 1983 .

Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine.

N. Bodor, H. Farag, 1983, Journal of medicinal chemistry.

Techniques of Solubilization of Drugs. (Drugs and the Pharmaceutical Sciences Series, Vol 12.)

N. Bodor, 1984 .

Direct evidence for brain-specific release of dopamine from a redox delivery system.

N. Bodor, J. Simpkins, A. Enz, 1985, Journal of pharmaceutical sciences.

Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine in equilibrium with pyridinium salt type redox delivery system.

N. Bodor, H. Farag, 1983, Journal of medicinal chemistry.

A Redox-Based Chemical Delivery System that Enhances Estradiol Distribution to the Brain: Disposition Studies in the Rat

N. Bodor, M. Brewster, H. Derendorf, 1991, Pharmaceutical Research.

Anxiolytic activity of a brain delivery system for GABA

N. Bodor, Warren C. Stern, J. Simpkins, 2004, Psychopharmacology.

Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester.

N. Bodor, H. Farag, F. Omar, 1994, Journal of drug targeting.

The Drug Discovery and Development Process

Nicholas Bodor, Peter Buchwald, N. Bodor, 2012 .

Targeting of drugs to the brain.

N. Bodor, 1985, Methods in enzymology.

Evidence for prolonged suppression of stress-induced release of adrenocorticotropic hormone and corticosterone with a brain-enhanced dexamethasone-redox delivery system.

N. Bodor, J. Simpkins, M. Brewster, 1989, Neuroendocrinology.

Brain-enhanced delivery of testosterone using a chemical delivery system complexed with 2-hydroxypropyl-beta-cyclodextrin.

N. Bodor, J. Simpkins, M. Brewster, 1988, Drug design and delivery.

QSAR Study of 2,3‐Benzodiazepin‐4(thi)one‐ and 1,2‐Phthalazine‐Related Negative Allosteric Modulators of the AMPA Receptor: A Structural Descriptors‐Based Reassessment

N. Bodor, P. Buchwald, B. Einstein, 2005 .

Facile, One-Step Preparation of Trigonellinate Esters

N. Bodor, M. Brewster, E. Shek, 1987 .

Effect of molecular manipulation on the estrogenic activity of a brain-targeting estradiol chemical delivery system.

N. Bodor, M. Brewster, P. Druzgala, 1994, Journal of medicinal chemistry.

Chemical systems for delivery of antiepileptic drugs to the central nervous system

N. Bodor, E. Pop, 1992, Epilepsy Research.

Tissue distribution of a brain-enhanced chemical delivery system for estradiol.

N. Bodor, J. Simpkins, M. Rahimy, 1990, Drug design and delivery.

Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue.

N. Bodor, L. Prokai, K. Prokai-Tatrai, 1999, Journal of medicinal chemistry.

Improved delivery through biological membranes. 32. Synthesis and biological activity of brain-targeted delivery systems for various estradiol derivatives.

N. Bodor, M. Brewster, K. S. Estes, 1988, Journal of medicinal chemistry.

Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.

N. Bodor, T. Loftsson, 1989, Acta pharmaceutica Nordica.

Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.

N. Bodor, E. Shek, E. Pop, 1989, Journal of Medicinal Chemistry.

Brain-targeted delivery of peptides

N. Bodor, P. Buchwald, 2006 .

Theoretical am1 studies of inclusion complexes of α- and β-cyclodextrins with methylated benzoic acids and phenol, and γ-cyclodextrin with buckminsterfullerene

N. Bodor, J. Watts, Ming-Ju Huang, 1996 .

Metabolism, Distribution, and Transdermal Permeation of a Soft Corticosteroid, Loteprednol Etabonate

N. Bodor, T. Loftsson, Whei-mei Wu, 1992, Pharmaceutical Research.

Soft Drugs 18. Oral and Rectal Delivery of Loteprednol Etabonate, a Novel Soft Corticosteroid, in Rats—for Safer Treatment of Gastrointestinal Inflammation

N. Bodor, T. Murakami, Whei-mei Wu, 1995, Pharmaceutical Research.

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2

N. Bodor, M. Katovich, T. Loftsson, 1984, Pharmaceutical Research.

All in the mind

N. Bodor, P. Buchwald, 1998 .

Mechanism of Drug Action: Basic Concepts

N. Bodor, P. Buchwald, 2012 .

A CONVENIENT SYNTHESIS OF (ACYLOXY)ALKYL α-ETHERS OF PHENOLS

N. Bodor, K. Sloan, J. Kaminski, 1984 .

Syntheses and Preliminary Pharmacological Evaluation of Some Chemical Delivery Systems of 2,6‐Diisopropylphenol (Propofol).

N. Bodor, M. Brewster, K. Prokai-Tatrai, 1992 .

A rapid, quantitative in vivo assay for narcotic antagonists.

N. Bodor, J. Simpkins, M. Katovich, 1984, Substance and alcohol actions/misuse.

Borohydride reduction of imidazolidino[1,2-d]dithiadiazepines

N. Bodor, L. Prokai, E. Koltai, 1992 .

A study of the penetration of five novel synthetic steroids through hairless mouse skin in vitro

N. Bodor, B. B. Michniak‐Mikolajczak, 1985, International Journal of Cosmetic Science.

A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats.

N. Bodor, M. Brewster, K. S. Estes, 1988, Life sciences.

Glossary and tutorial of xenobiotic metabolism terms used during small molecule drug discovery and development (IUPAC Technical Report)

N. Bodor, S. Wrighton, H. Masumoto, 2021, Pure and Applied Chemistry.

A theoretical study of prednisolone, 6α-fluoroprednisolone, 9α-fluoroprednisolone, 6α,9α-difluoroprednisolone and related compounds

N. Bodor, Ming-Ju Huang, J. Kaminski, 1993 .

Enhanced Activity of Topical Hydrocortisone by Competitive Binding of Corticosteroid-Binding Globulin.

N. Bodor, Whei-mei Wu, Erik T. Bodor, 2016, Journal of pharmaceutical sciences.

Nitrogen radical cations as intermediates in enzymatically mediated oxidative deaminations—application of molecular parametric models

N. Bodor, M. Brewster, D. Doerge, 1995 .

AM1-BASED MODEL SYSTEM FOR ESTIMATION OF BRAIN/BLOOD CONCENTRATION RATIOS

N. Bodor, M. Brewster, E. Pop, 1996 .

A study of the penetration of five novel synthetic steroids through hairless mouse skin in vitro

N. Bodor, B. B. Michniak-Mikolajczak, 1985, International journal of cosmetic science.

Anesthetic Activity and Pharmacokinetics of the Neurosteroid Alfaxalone Formulated In 2-Hydroxypropyl-β-Cyclodextrin in the Rat

N. Bodor, M. Brewster, W. Anderson, 1996 .

Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugs.

N. Bodor, T. Loftsson, 1981, Journal of pharmaceutical sciences.

Effect of 2-Hydroxypropyl-β-Cyclodextrin Complexes of the Neurosteroids, Alfaxalone, Pregnanolone and Pregnenolone, on Various Convulsant Stimuli in the Mouse

N. Bodor, M. Brewster, T. Loftsson, 1996 .

Minimal cardiac electro-physiological activity of alprenoxime, a site-activated ocular β-blocker, in dogs

N. Bodor, P. Polgár, 1995 .

Recent advances in retrometabolic drug design (RMDD) and development.

N. Bodor, P. Buchwald, 2010, Die Pharmazie.